title: [Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].
authors.affiliation: Département des Interactions cellulaires et moléculaires, Vlaams Interuniversitair Instituut voor Biotechnologie, Laboratorium voor Cellulaire en Moleculaire Immunologie, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Bruxelles, Belgique. tbaral@vub.ac.be
authors.forename: Toya Nath
authors.initials: TN
authors.lastname: Baral
authors.forename: Stefan
authors.initials: S
authors.lastname: Magez
authors.forename: Benoît
authors.initials: B
authors.lastname: Stijlemans
authors.forename: Katja
authors.initials: K
authors.lastname: Conrath
authors.forename: Benoit
authors.initials: B
authors.lastname: Vanhollebeke
authors.forename: Etienne
authors.initials: E
authors.lastname: Pays
authors.forename: Serge
authors.initials: S
authors.lastname: Muyldermans
authors.forename: Patrick
authors.initials: P
authors.lastname: De Baetselier
mesh_terms: D001798:Blood Proteins / Q000627:therapeutic use*; D006801:Humans; D049329:Nanostructures / Q000627:therapeutic use*; D014344:Trypanocidal Agents / Q000627:therapeutic use*; D014353:Trypanosomiasis, African / Q000188:drug therapy*
chemical_list: D001798:Blood Proteins; D014344:Trypanocidal Agents